학술논문

Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial
Document Type
Article
Source
In: The Lancet Neurology. (The Lancet Neurology, January 2024, 23(1):37-45)
Subject
Language
English
ISSN
14744465
14744422